Events

The fight against COVID: Has the U.S. entered a new normal?

Illustration of man on ladder above the COVID virus

The fight against COVID: Has the U.S. entered a new normal?

Guian McKee, J. Stephen Morrison, Margaret Foster Riley

Wednesday, March 30, 2022
11:00AM - 12:00PM (EDT)
Event Details

In early March, the White House unveiled its new coronavirus response strategy aimed at creating what some are calling the beginning of a “new normal” in the nation’s fight against COVID-19. As the Omicron wave continues its decline and several states loosen pandemic-related restrictions, our experts are having a “state of the pandemic” discussion that will assess the rapidly shifting public health approach, what the U.S. role will be in the global efforts to deal with COVID, and what we might expect in the months ahead.

For the protection of our staff, faculty, and guests, the Miller Center strongly encourages visitors to be fully vaccinated against COVID-19 and recommends that unvaccinated patrons watch the event online. We also encourage you to wear a mask during our events. Paper masks are available for in-person attendees.

By registering to attend this event, you agree that you will observe all COVID-19 safety requirements in effect at the time under UVA Policy SEC-045.

When
Wednesday, March 30, 2022
11:00AM - 12:00PM (EDT)
Where
The Miller Center
2201 Old Ivy Rd
Charlottesville, VA
&
Online webinar
Speakers
Guian McKee headshot

Guian McKee

Guian McKee is an associate professor in presidential studies at the Miller Center. He received a Ph.D. in American history at the University of California, Berkeley, in May 2002, and is the author of The Problem of Jobs: Liberalism, Race, and Deindustrialization in Philadelphia (University of Chicago Press, 2008). At the Miller Center, McKee works extensively with the Presidential Recordings Program. His research focuses on how federal policy, especially in the executive branch, plays out at the local level in American communities. He has written extensively about urban policy, including a book that explored the connections between local and federal economic, urban renewal, and antipoverty policies in Philadelphia between the 1950s and the 1980s.

Steve Morrison headshot

J. Stephen Morrison

J. Stephen Morrison is a senior vice president at the Center for Strategic and International Studies (CSIS) in Washington D.C., where he founded and directs its Global Health Policy Center. A political scientist, he has built over the past two decades a highly dynamic and impactful program that concentrates on the geopolitical and national security dimensions of U.S. leadership in international health, with a special emphasis upon the centrality of bipartisanship and multilateral institutions, partnerships with private industry, foundations, advocates and the faith community, and long-term strategic planning and commitments.

Through a series of high-level commissions that he has created and directed, Morrison has spearheaded work that has shaped concrete decisions in Congress and the administration on HIV/AIDS, malaria, tuberculosis, reproductive health and gender equality, immunizations, and health security, including pandemic preparedness, acceleration of technological innovations, and coping with anti-science and a polluted digital world. 

Mimi Riley headshot

Margaret Foster Riley

Margaret Foster Riley, Dorothy Danforth Compton Professor at the Miller Center, is professor of law at UVA Law School, professor of public health sciences at the UVA School of Medicine, and professor of public policy at the University’s Frank Batten School of Leadership and Public Policy. She also directs the Animal Law Program at the law school.

A scholar working in the intersection of law, regulation, policy, and ethics in the Life Sciences, Riley has written and presented extensively about health care law, biomedical research, genetics, food and drug regulation, reproductive technologies, human and animal biotechnology, and public health. She is currently a member of the NIH NExTRAC, a FACA committee that advises the NIH Director on issues concerning emerging biotechnologies. She served on four National Academies committees: the Committees on Revisions to the Common Rule for the Protection of Human Subjects, Assessing Toxicological Risks to Human Subjects, Assessment of the Care and Use of Dogs in Biomedical Research Funded by or Conducted at the U.S. Department of Veterans Affairs, and Pain Management and Regulatory Strategies to Reduce Prescription Opioid Abuse (consultant to the committee).